Quantitative Transmission Imaging Evaluation With MRI as Supplemental Screening to Mammography in Patients With High Lifetime Risk of Breast Cancer

Overview

About this study

The purpose of this study is to perform a prospective feasibility study with a goal of n=25 to compare the screening performance of QTI to MRI and other standard of care imaging in patients with high lifetime risk of developing breast cancer. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women 18+ years of age.
  • High lifetime risk of breast cancer as determined by a risk assessment tool such a Tyrer-Cuzick model.
  • Clinical ordered screening MRI and DBT screen.
    • Imaging preferably performed within 90 days of each other.
    • MRI and QTI performed within 30 days of each other.
  • Breasts that will fit in the QT Ultrasound Breast Scanner (e.g. bra cup size less than DDD)

Exclusion Criteria: 

  • Pregnant patients.
  • Lactating patients.
  • Patients with open wounds or discharge.
  • Patients < 18 years of age.
  • Patients who are > 350 lbs.
  • Patients who are unable to lay prone for >15 minutes.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Tiffany Sae-Kho, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available